First Manhattan CO Karuna Therapeutics, Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $1.17 Million - $1.69 Million	-10,600 Reduced 33.01%	21,510 $2.82 Million
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $3.31 Million - $4.62 Million	-34,726 Reduced 51.96%	32,110 $3.86 Million
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $2.16 Million - $3.33 Million	30,300 Added 82.93%	66,836 $5.17 Million
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $1.35 Million - $2.55 Million	-21,764 Reduced 37.33%	36,536 $4.07 Million
Q4 2019 Feb 13, 2020	BUY	$11.44 - $123.99 $666,952 - $7.23 Million	58,300 New	58,300 $4.39 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.